Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian-R Mackay

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Arthritis and Rheumatism|June 4, 2005
Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cellsS Fatemah Amirahmadi, Senga Whittingham, Duncan E Crombie, et al.
Hepatology (Baltimore, Md.)|November 13, 2009
CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosisShinji Shimoda, Kenichi Harada, Hiroaki Niiro, et al.
Immunology and Cell Biology|July 4, 2007
Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entryChristoph Königs, Anette Pustowka, James Irving, et al.
Journal of Autoimmunity|July 23, 2008
CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosisShinji Shimoda, Hiroshi Miyakawa, Minoru Nakamura, et al.
Diabetes|January 11, 2008
COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivityGustavo Fenalti, Christiane S Hampe, Yasir Arafat, et al.
Hepatology (Baltimore, Md.)|February 3, 2009
Apotopes and the biliary specificity of primary biliary cirrhosisAna Lleo, Carlo Selmi, Pietro Invernizzi, et al.
Hepatology (Baltimore, Md.)|October 31, 2009
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative miceYuki Moritoki, Zhe-Xiong Lian, Keith Lindor, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II miceKatsunori Yoshida, Guo-Xiang Yang, Weici Zhang, et al.
Gastroenterology|September 20, 2015
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Journal of Hepatology|September 20, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Arthritis and Rheumatism|June 4, 2005
Arthritogenic anti-type II collagen antibodies are pathogenic for cartilage-derived chondrocytes independent of inflammatory cellsS Fatemah Amirahmadi, Senga Whittingham, Duncan E Crombie, et al.
Hepatology (Baltimore, Md.)|November 13, 2009
CX3CL1 (fractalkine): a signpost for biliary inflammation in primary biliary cirrhosisShinji Shimoda, Kenichi Harada, Hiroaki Niiro, et al.
Immunology and Cell Biology|July 4, 2007
Peptide mimotopes selected with HIV-1-blocking monoclonal antibodies against CCR5 represent motifs specific for HIV-1 entryChristoph Königs, Anette Pustowka, James Irving, et al.
Journal of Autoimmunity|July 23, 2008
CD4 T-cell autoreactivity to the mitochondrial autoantigen PDC-E2 in AMA-negative primary biliary cirrhosisShinji Shimoda, Hiroshi Miyakawa, Minoru Nakamura, et al.
Diabetes|January 11, 2008
COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivityGustavo Fenalti, Christiane S Hampe, Yasir Arafat, et al.
Hepatology (Baltimore, Md.)|February 3, 2009
Apotopes and the biliary specificity of primary biliary cirrhosisAna Lleo, Carlo Selmi, Pietro Invernizzi, et al.
Hepatology (Baltimore, Md.)|October 31, 2009
B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative miceYuki Moritoki, Zhe-Xiong Lian, Keith Lindor, et al.
Hepatology (Baltimore, Md.)|August 14, 2009
Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II miceKatsunori Yoshida, Guo-Xiang Yang, Weici Zhang, et al.
Gastroenterology|September 20, 2015
Changing nomenclature for PBC: from 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Journal of Hepatology|September 20, 2015
Changing nomenclature for PBC: From 'cirrhosis' to 'cholangitis'Ulrich Beuers, M Eric Gershwin, Robert G Gish, et al.
Pageof 8